189 related articles for article (PubMed ID: 10556187)
1. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2.
Levin J; Peng JP; Baker GR; Villeval JL; Lecine P; Burstein SA; Shivdasani RA
Blood; 1999 Nov; 94(9):3037-47. PubMed ID: 10556187
[TBL] [Abstract][Full Text] [Related]
2. Ablation of Nrf2 function does not increase the erythroid or megakaryocytic cell lineage dysfunction caused by p45 NF-E2 gene disruption.
Kuroha T; Takahashi S; Komeno T; Itoh K; Nagasawa T; Yamamoto M
J Biochem; 1998 Mar; 123(3):376-9. PubMed ID: 9538217
[TBL] [Abstract][Full Text] [Related]
3. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2.
Shivdasani RA; Orkin SH
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8690-4. PubMed ID: 7567998
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes.
Lecine P; Villeval JL; Vyas P; Swencki B; Xu Y; Shivdasani RA
Blood; 1998 Sep; 92(5):1608-16. PubMed ID: 9716588
[TBL] [Abstract][Full Text] [Related]
5. The role of transcription factor NF-E2 in megakaryocyte maturation and platelet production.
Shivdasani RA
Stem Cells; 1996; 14 Suppl 1():112-5. PubMed ID: 11012210
[TBL] [Abstract][Full Text] [Related]
6. Consequences of GATA-1 deficiency in megakaryocytes and platelets.
Vyas P; Ault K; Jackson CW; Orkin SH; Shivdasani RA
Blood; 1999 May; 93(9):2867-75. PubMed ID: 10216081
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice.
Shivdasani RA; Fielder P; Keller GA; Orkin SH; de Sauvage FJ
Blood; 1997 Sep; 90(5):1821-7. PubMed ID: 9292514
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.
Shivdasani RA; Rosenblatt MF; Zucker-Franklin D; Jackson CW; Hunt P; Saris CJ; Orkin SH
Cell; 1995 Jun; 81(5):695-704. PubMed ID: 7774011
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular biology of megakaryocyte differentiation in the absence of lineage-restricted transcription factors.
Lecine P; Shivdasani RA
Stem Cells; 1998; 16 Suppl 2():91-5. PubMed ID: 11012181
[TBL] [Abstract][Full Text] [Related]
10. Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype.
Kacena MA; Gundberg CM; Nelson T; Horowitz MC
Bone; 2005 Feb; 36(2):215-23. PubMed ID: 15780947
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the hematopoietic transcription factor NF-E2 in primary murine megakaryocytes.
Lecine P; Blank V; Shivdasani R
J Biol Chem; 1998 Mar; 273(13):7572-8. PubMed ID: 9516460
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the two alternative promoters of human p45 NF-E2 gene.
Toki T; Arai K; Terui K; Komatsu N; Yokoyama M; Katsuoka F; Yamamoto M; Ito E
Exp Hematol; 2000 Oct; 28(10):1113-9. PubMed ID: 11027829
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2.
Lecine P; Italiano JE; Kim SW; Villeval JL; Shivdasani RA
Blood; 2000 Aug; 96(4):1366-73. PubMed ID: 10942379
[TBL] [Abstract][Full Text] [Related]
14. p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes.
Deveaux S; Cohen-Kaminsky S; Shivdasani RA; Andrews NC; Filipe A; Kuzniak I; Orkin SH; Roméo PH; Mignotte V
EMBO J; 1997 Sep; 16(18):5654-61. PubMed ID: 9312024
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2.
Kacena MA; Shivdasani RA; Wilson K; Xi Y; Troiano N; Nazarian A; Gundberg CM; Bouxsein ML; Lorenzo JA; Horowitz MC
J Bone Miner Res; 2004 Apr; 19(4):652-60. PubMed ID: 15005853
[TBL] [Abstract][Full Text] [Related]
16. Mouse microcytic anaemia caused by a defect in the gene encoding the globin enhancer-binding protein NF-E2.
Peters LL; Andrews NC; Eicher EM; Davidson MB; Orkin SH; Lux SE
Nature; 1993 Apr; 362(6422):768-70. PubMed ID: 8469289
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis.
Catani L; Vianelli N; Amabile M; Pattacini L; Valdrè L; Fagioli ME; Poli M; Gugliotta L; Moi P; Marini MG; Martinelli G; Tura S; Baccarani M
Leukemia; 2002 Sep; 16(9):1773-81. PubMed ID: 12200693
[TBL] [Abstract][Full Text] [Related]
18. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin.
Terui K; Takahashi Y; Kitazawa J; Toki T; Yokoyama M; Ito E
Tohoku J Exp Med; 2000 Dec; 192(4):259-73. PubMed ID: 11286316
[TBL] [Abstract][Full Text] [Related]
19. Abnormal differentiation of erythroid precursors in p45 NF-E2(-/-) mice.
Gasiorek JJ; Nouhi Z; Blank V
Exp Hematol; 2012 May; 40(5):393-400. PubMed ID: 22265708
[TBL] [Abstract][Full Text] [Related]
20. Molecular and transcriptional regulation of megakaryocyte differentiation.
Shivdasani RA
Stem Cells; 2001; 19(5):397-407. PubMed ID: 11553848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
